PT
Pillar Therapeutics, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$14Msold at filing
Total offering$25M$11M still open
Investors in the raise2count reported to the SEC
FiledMay 13, 2026first sale Apr 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
JENNA HEBERTDirector
COSMAS GIALLOURAKISVExecutive Officer, Director, Promoter
TESS CAMERONDirector
AMANDA CREEDONExecutive Officer
Executive officers, directors and promoters as listed on the Form D.